# Radiaction

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/radiaction

- Industry: Medical Devices & Equipment
- Headquarters: Tel-Aviv, Israel
- Website: www.radiactionmedical.com
- Total disclosed funding: $13M
- Latest round: Series C (Aug 29, 2023)
- Investors on record: 1

## About

Based in Israel, Radiaction Ltd. specializes in innovative radiation protection systems designed to enhance safety for healthcare professionals during fluoroscopic procedures.Radiaction Ltd. was founded in 2014 and is headquartered in Tel-Aviv, Israel. The company focuses on advanced solutions for scatter radiation protection, primarily in the field of interventional cardiology and electrophysiology. Amir Belson is the founder, while Jonathan Yifat serves as CEO. In August 2023, Radiaction raised USD 12.6 mn in Series C funding, led by InnovaHealth Partners, bringing the total amount raised to USD 12.6 mn across 4 deals.Radiaction Medical specializes in advanced scatter radiation protection systems designed to safeguard physicians and healthcare staff during fluoroscopic procedures. Their core product, the Radiaction System, deploys a dynamic barrier that effectively blocks scatter radiation at the source, rather than relying on traditional personnel shielding. This innovative technology allows for quick deployment and retraction within 2-3 seconds, maintaining workflow efficiency while providing immediate access to patients. Radiaction's solutions are utilized primarily in interventional cardiology and electrophysiology, serving a diverse client base that includes hospitals and medical centers across various geographical markets such as North America, Europe, and Asia. The company aims to meet occupational safety standards for radiation exposure, contributing to a safer working environment for healthcare professionals.Radiaction Medical generates revenue through direct sales of its radiation protection systems, typically involving business-to-business transactions with medical facilities. Hospitals purchase the Radiaction System as a capital investment to enhance their operational safety protocols. The transaction structure may include service agreements for ongoing support and maintenance of the systems, ensuring optimal performance. Pricing plans are tailored to the specific needs of each client, with considerations for the scale of their operations and the volume of procedures conducted. The flagship Radiaction System is central to these transactions, providing a comprehensive solution for managing radiation exposure in medical environments.In August 2023, Radiaction Ltd. raised USD 12.6 mn in Series C funding, led by InnovaHealth Partners, to support its growth initiatives. The company is currently developing new product offerings aimed at expanding its market presence. Plans include entering new geographic regions, particularly targeting markets in Asia and Europe by 2025. The recent funding will be aimed at accelerating product development and facilitating market entry strategies.

## Funding rounds

- Series C, Aug 29, 2023, $13M — InnovaHealth Partners

## Investors

- InnovaHealth Partners (https://capitalatlas.ai/funds/innovahealth-partners) — Series C